Investigating the FLiRT variants of COVID-19: Is it an emerging concern?

被引:7
|
作者
Aden, Durre [1 ]
Zaheer, Sufian [2 ]
机构
[1] Jamia Hamdard, HIMSR, Dept Pathol, New Delhi, India
[2] VMMC, Dept Pathol, New Delhi, India
关键词
COVID-19; FLiRT Variants; Severe acute respiratory syndrome coronavirus; SARS-CoV-2; 2; IMMUNE ESCAPE; SARS-COV-2; TRANSMISSION;
D O I
10.1016/j.prp.2024.155542
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The ongoing COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to multiple waves of infections globally. As the virus continues to evolve, new variants have emerged, some with concerning changes in transmissibility and virulence. Among these variants, the "FLiRT Variants" have recently gained attention due to their potential to alter the dynamics of transmission and disease severity. According to the Infectious Disease Society of America, the nickname 'FLiRT' is based on the technical names for their mutations. The FLiRT variants, particularly KP.2, seem to exhibit heightened transmissibility in comparison to earlier Omicron sub-variants. Additionally, they demonstrate a capacity to evade immunity conferred by prior infection and vaccines, although the full extent of this evasion is still being investigated. In this article, we review the characteristics of the FLiRT variants, including their genetic mutations, epidemiological features, potential impact on public health measures, and implications for vaccine efficacy. We also discuss strategies for surveillance, prevention, and mitigation efforts to control the spread of this variant and mitigate its impact on global health.
引用
收藏
页数:4
相关论文
共 50 条
  • [31] Genome Organization of Covid-19 and Emerging Severe Acute Respiratory Syndrome Covid-19 Outbreak: A Pandemic
    Dagur, Hanuman Singh
    Dhakar, Saurabh Singh
    EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY, 2020, 4 (02): : 107 - 115
  • [32] Biomass use and COVID-19: A novel concern
    Thakur, Megha
    Boudewijns, Esther A.
    Babu, Giridhara R.
    van Schayck, Onno C. P.
    ENVIRONMENTAL RESEARCH, 2020, 186
  • [33] Visuospatial impairment is of concern in patients with COVID-19
    Nouraeinejad, Ali
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2024, 134 (07) : 810 - 811
  • [34] COVID-19: A Concern for Cardiovascular Disease Patients
    Sharma, Shruti
    CARDIOVASCULAR TOXICOLOGY, 2020, 20 (05) : 443 - 447
  • [35] COVID-19: A Concern for Cardiovascular Disease Patients
    Shruti Sharma
    Cardiovascular Toxicology, 2020, 20 : 443 - 447
  • [36] COVID-19: An International Public Health Concern
    Ayenigbara, Israel Oluwasegun
    CENTRAL ASIAN JOURNAL OF GLOBAL HEALTH, 2020, 9 (01):
  • [37] COVID-19 During Development: A Matter of Concern
    Saavedra, Lucas Paulo Jacinto
    Prates, Kelly Valerio
    Goncalves, Gessica Dutra
    Piovan, Silvano
    Matafome, Paulo
    Mathias, Paulo Cezar de Freitas
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [38] COVID 19 pandemic - A need for emerging concern in dental practice
    Deshmukh, Seema
    Murthy, Prashanth Sadashiva
    Ravindra, S.
    INTERNATIONAL JOURNAL OF HEALTH AND ALLIED SCIENCES, 2020, 9 : 85 - 90
  • [39] Emerging SARS-CoV-2 Variants in Uganda in the Era of COVID-19 Vaccination
    Bbosa, Nicholas
    Kiiza, Ronald
    Ssekagiri, Alfred
    Namagembe, Hamidah Suubi
    Nabirye, Stella Esther
    Kabuuka, Danstan
    Rwankindo, Cleophous
    Kisakye, Annet
    Woldemariam, Yonas T.
    Kusemererwa, Sylvia
    Ongaria, Terry A.
    Kakande, Ayoub
    Abaasa, Andrew
    Kimbugwe, Geofrey
    Bosa, Henry Kyobe
    Driwale, Alfred
    Mwenda, Jason M.
    Worwui, Archibald K.
    Humphreys, James
    Cohuet, Sandra
    Elliott, Alison M.
    Ruzagira, Eugene
    Kaleebu, Pontiano
    Ssemwanga, Deogratius
    VIRUSES-BASEL, 2024, 16 (12):
  • [40] Emerging Evidence for Neuropsycho-Consequences of COVID-19
    Li, Jingwen
    Long, Xi
    Zhang, Qing
    Fang, Xi
    Fang, Fang
    Lv, Xuefei
    Zhang, Dandan
    Sun, Yu
    Li, Na
    Hu, Shaoping
    Lin, Zhicheng
    Xiong, Nian
    CURRENT NEUROPHARMACOLOGY, 2021, 19 (01) : 92 - 96